• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶-7和基质金属蛋白酶-9与浅表性食管癌的不良预后相关。

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.

作者信息

Tanioka Y, Yoshida T, Yagawa T, Saiki Y, Takeo S, Harada T, Okazawa T, Yanai H, Okita K

机构信息

Department of Gastroenterology and Hepatology, Yamaguchi University School of Medicine, Ube, Yamaguchi, Japan.

出版信息

Br J Cancer. 2003 Dec 1;89(11):2116-21. doi: 10.1038/sj.bjc.6601372.

DOI:10.1038/sj.bjc.6601372
PMID:14647147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2376843/
Abstract

If oesophageal carcinoma is detected in the superficial stage, the prognosis is better than for advanced oesophageal carcinoma. But the factors which predict the prognosis and treatment policy remain unclear. Matrix metalloproteinase-7 (MMP-7) and matrix metalloproteinase-9 (MMP-9) have been reported to have close associations with tumour invasion and metastasis. In this study, we retrospectively studied the relations between MMP-7 and MMP-9 expression in immunohistochemistry, clinicopathologic factors, and prognosis in 55 superficial oesophageal carcinomas. MMP-7 and MMP-9 expression occurred in 23.6% and 47.3% of the patients, respectively. MMP-7 expression was significantly correlated with the presence of nodal metastasis (P=0.004). MMP-9 expression was significantly correlated with the depth of tumour invasion (P=0.004), lymphatic permeation (P=0.001), nodal metastasis (P=0.049), and pathologic differentiation grade (P=0.003). By the log-rank test, MMP-7 expression and MMP-9 expression on the invasive front were related to the prognosis. In multivariate analysis, MMP-9 expression on the invasive front was an independent prognostic indicator. The combined expression of MMP-7 and MMP-9 may be a good marker for the degree of malignancy of oesophageal cancer and for the presence of lymphatic metastasis.

摘要

如果在浅表阶段检测到食管癌,其预后优于晚期食管癌。但预测预后和治疗策略的因素仍不明确。据报道,基质金属蛋白酶-7(MMP-7)和基质金属蛋白酶-9(MMP-9)与肿瘤侵袭和转移密切相关。在本研究中,我们回顾性研究了55例浅表食管癌患者免疫组化中MMP-7和MMP-9表达、临床病理因素与预后之间的关系。MMP-7和MMP-9表达分别出现在23.6%和47.3%的患者中。MMP-7表达与淋巴结转移的存在显著相关(P=0.004)。MMP-9表达与肿瘤浸润深度(P=0.004)、淋巴管浸润(P=0.001)、淋巴结转移(P=0.049)和病理分化程度(P=0.003)显著相关。通过对数秩检验,侵袭前沿的MMP-7表达和MMP-9表达与预后相关。在多变量分析中,侵袭前沿的MMP-9表达是一个独立的预后指标。MMP-7和MMP-9的联合表达可能是食管癌恶性程度和淋巴转移存在的良好标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b9b/2376843/2bf2a9416b10/89-6601372f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b9b/2376843/1c848c60f796/89-6601372f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b9b/2376843/0c118678535d/89-6601372f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b9b/2376843/2bf2a9416b10/89-6601372f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b9b/2376843/1c848c60f796/89-6601372f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b9b/2376843/0c118678535d/89-6601372f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b9b/2376843/2bf2a9416b10/89-6601372f3.jpg

相似文献

1
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer.基质金属蛋白酶-7和基质金属蛋白酶-9与浅表性食管癌的不良预后相关。
Br J Cancer. 2003 Dec 1;89(11):2116-21. doi: 10.1038/sj.bjc.6601372.
2
Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.基质金属蛋白酶-1与食管癌的不良预后相关。
J Pathol. 1998 Jul;185(3):256-61. doi: 10.1002/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A.
3
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.基质金属蛋白酶7、9及膜型1基质金属蛋白酶在食管鳞状细胞癌中的表达增加。
Cancer. 2000 May 15;88(10):2201-9.
4
MMP-7, MMP-8, and MMP-9 in oral and cutaneous squamous cell carcinomas.口腔和皮肤鳞状细胞癌中的基质金属蛋白酶-7、基质金属蛋白酶-8和基质金属蛋白酶-9
Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Apr;119(4):459-67. doi: 10.1016/j.oooo.2014.12.019. Epub 2015 Jan 6.
5
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.基质金属蛋白酶-7(MMP-7)在胃癌侵袭前沿的表达的预后意义。
Jpn J Cancer Res. 2002 Mar;93(3):291-5. doi: 10.1111/j.1349-7006.2002.tb02171.x.
6
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.基质金属蛋白酶及其组织抑制剂在人胰腺腺癌中的表达:基质溶素表达的临床病理及预后意义
J Clin Oncol. 2001 Feb 15;19(4):1118-27. doi: 10.1200/JCO.2001.19.4.1118.
7
Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography.基质金属蛋白酶-2和-9在食管癌中的明胶酶活性;一项使用原位酶谱法的研究
Eur J Cancer. 2000 Oct;36(16):2164-70. doi: 10.1016/s0959-8049(00)00297-5.
8
Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer.Twist和基质金属蛋白酶-9的过表达与胃癌转移及预后的关系
Asian Pac J Cancer Prev. 2013;14(9):5055-60. doi: 10.7314/apjcp.2013.14.9.5055.
9
Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma.基质金属蛋白酶-2和基质金属蛋白酶-9在口腔鳞状细胞癌中的表达及临床意义
Oral Oncol. 2005 Mar;41(3):283-93. doi: 10.1016/j.oraloncology.2004.08.013.
10
Matrix metalloproteinase-7 and matrix metalloproteinase-25 in oral tongue squamous cell carcinoma.口腔舌鳞状细胞癌中的基质金属蛋白酶-7和基质金属蛋白酶-25
Head Neck. 2014 Dec;36(12):1783-8. doi: 10.1002/hed.23539. Epub 2014 Feb 1.

引用本文的文献

1
Matrix Metalloproteinase 9 Induced in Esophageal Squamous Cell Carcinoma Cells via Close Contact with Tumor-Associated Macrophages Contributes to Cancer Progression and Poor Prognosis.通过与肿瘤相关巨噬细胞密切接触在食管鳞状细胞癌细胞中诱导产生的基质金属蛋白酶9促进癌症进展并导致预后不良。
Cancers (Basel). 2023 May 30;15(11):2987. doi: 10.3390/cancers15112987.
2
Drug repositioning for esophageal squamous cell carcinoma.用于食管鳞状细胞癌的药物重新定位。
Front Genet. 2022 Sep 28;13:991842. doi: 10.3389/fgene.2022.991842. eCollection 2022.
3
Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis.

本文引用的文献

1
Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial.食管癌手术切除联合或不联合术前化疗:一项随机对照试验
Lancet. 2002 May 18;359(9319):1727-33. doi: 10.1016/S0140-6736(02)08651-8.
2
Matrix metalloproteinase 9 in mucosally invasive gastric cancer.基质金属蛋白酶9在黏膜浸润性胃癌中的作用
Gastric Cancer. 1998 Mar;1(2):142-145. doi: 10.1007/s101200050008.
3
Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.
同步放疗后转移性食管鳞状细胞癌患者血清基质金属蛋白酶-9降低对预后具有重要意义。
Onco Targets Ther. 2020 Dec 15;13:12857-12866. doi: 10.2147/OTT.S280791. eCollection 2020.
4
Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma.沉默 microRNA-330-5p 可增加 MMP1 表达并促进食管腺癌的侵袭表型。
BMC Cancer. 2019 Aug 7;19(1):784. doi: 10.1186/s12885-019-5996-3.
5
Amperometric Biosensor of Matrix Metalloproteinase-7 Enhanced by Pd-Functionalized Carbon Nanocomposites.钯功能化碳纳米复合材料增强的基质金属蛋白酶-7电流型生物传感器
Nanoscale Res Lett. 2018 Nov 22;13(1):375. doi: 10.1186/s11671-018-2793-x.
6
Matrix metalloproteinase (MMP)-7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance.基质金属蛋白酶(MMP)-7在巴雷特食管和食管腺癌中的表达、代谢及功能意义
Physiol Rep. 2018 May;6(10):e13683. doi: 10.14814/phy2.13683.
7
Oxymatrine induces apoptosis and inhibits invasion in Gallbladder carcinoma via PTEN/PI3K/AKT pathway.氧化苦参碱通过PTEN/PI3K/AKT途径诱导胆囊癌细胞凋亡并抑制其侵袭。
Cytotechnology. 2018 Feb;70(1):83-94. doi: 10.1007/s10616-017-0153-9. Epub 2017 Nov 23.
8
XBP1 induces MMP-9 expression to promote proliferation and invasion in human esophageal squamous cell carcinoma.XBP1诱导基质金属蛋白酶-9表达以促进人食管鳞状细胞癌的增殖和侵袭。
Am J Cancer Res. 2016 Sep 1;6(9):2031-2040. eCollection 2016.
9
Visible-absorption spectroscopy as a biomarker to predict treatment response and prognosis of surgically resected esophageal cancer.可视吸收光谱学作为一种生物标志物,可预测手术切除食管癌的治疗反应和预后。
Sci Rep. 2016 Sep 14;6:33414. doi: 10.1038/srep33414.
10
Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis.基质金属蛋白酶-7蛋白表达在食管癌中的临床病理意义:一项荟萃分析
Drug Des Devel Ther. 2015 Jul 20;9:3729-40. doi: 10.2147/DDDT.S85987. eCollection 2015.
基质金属蛋白酶-2和基质金属蛋白酶-9的表达与宫颈癌细胞侵袭能力之间的关系
Oncol Rep. 2002 May-Jun;9(3):565-9.
4
Prognostic significance of matrix metalloproteinase-7 (MMP-7) expression at the invasive front in gastric carcinoma.基质金属蛋白酶-7(MMP-7)在胃癌侵袭前沿的表达的预后意义。
Jpn J Cancer Res. 2002 Mar;93(3):291-5. doi: 10.1111/j.1349-7006.2002.tb02171.x.
5
Measuring gelatinase activity in colorectal cancer.测量结直肠癌中的明胶酶活性。
Eur J Surg Oncol. 2002 Feb;28(1):24-9. doi: 10.1053/ejso.2001.1179.
6
Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.胰腺癌中静脉侵犯的组织学特征、血管内皮生长因子及基质金属蛋白酶-2和基质金属蛋白酶-9的表达及其与肝转移的关系
Pancreas. 2002 Mar;24(2):169-78. doi: 10.1097/00006676-200203000-00008.
7
Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.基质溶素在人类结直肠癌浸润前沿的表达的临床病理及预后意义
Int J Cancer. 2001 Sep 20;95(5):290-4. doi: 10.1002/1097-0215(20010920)95:5<290::aid-ijc1050>3.0.co;2-i.
8
Endoscopic mucosal resection for early esophageal cancer and esophageal dysplasia.早期食管癌和食管发育异常的内镜黏膜切除术
Hepatogastroenterology. 2001 Mar-Apr;48(38):453-7.
9
Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography.基质金属蛋白酶-2和-9在食管癌中的明胶酶活性;一项使用原位酶谱法的研究
Eur J Cancer. 2000 Oct;36(16):2164-70. doi: 10.1016/s0959-8049(00)00297-5.
10
Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas.基质金属蛋白酶7、9及膜型1基质金属蛋白酶在食管鳞状细胞癌中的表达增加。
Cancer. 2000 May 15;88(10):2201-9.